Skip to main content

Tower Research Capital LLC (TRC)

Position in ANTX — AN2 Therapeutics, Inc.

CIK 1533421 NEW YORK, NY

Position in ANTX

as of Jun 30, 2026 · filed Aug 11, 2026
Position Value
$8,745
+$6,782 QoQ
Shares Held
1,807
+214.8% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#59
of 66 holders
Holding Since
Mar 2022
17 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ANTX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Tower Research Capital LLC (TRC) holds $49,479,230 across 466 Biotechnology names. ANTX ranks #313 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in ANTX

Export CSV
17 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $8,745 1,807
2026-03-31 $1,963 574
2025-12-31 $2,325 2,040
2025-09-30 $2,702 2,128
2025-06-30 $5,631 5,313
2025-03-31 $2,831 2,082
2024-12-31 $2,018 1,463
2024-09-30 $4,553 4,256
2024-06-30 $11,622 5,406
2024-03-31 $3,617 1,113
2023-12-31 $1,290 63
2023-09-30 $48,963 3,045
2023-03-31 $27,606 2,797
2022-12-31 $8,157 856
2022-09-30 $22,229 1,279
2022-06-30 $33,805 4,362
2022-03-31 $9,840 653